rs769772100
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_004813.4(PEX16):c.859C>T(p.Arg287Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R287H) has been classified as Pathogenic.
Frequency
Consequence
NM_004813.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX16 | NM_004813.4 | c.859C>T | p.Arg287Cys | missense_variant | 9/11 | ENST00000378750.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX16 | ENST00000378750.10 | c.859C>T | p.Arg287Cys | missense_variant | 9/11 | 1 | NM_004813.4 | P1 | |
PEX16 | ENST00000241041.7 | c.859C>T | p.Arg287Cys | missense_variant | 9/11 | 1 | |||
PEX16 | ENST00000532681.5 | c.574C>T | p.Arg192Cys | missense_variant | 9/11 | 3 | |||
PEX16 | ENST00000533151.5 | c.547C>T | p.Arg183Cys | missense_variant | 6/6 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250094Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135460
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461434Hom.: 0 Cov.: 37 AF XY: 0.0000110 AC XY: 8AN XY: 727060
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 15, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg287 amino acid residue in PEX16. Other variant(s) that disrupt this residue have been observed in individuals with PEX16-related conditions (PMID: 31227335), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PEX16 protein function. ClinVar contains an entry for this variant (Variation ID: 561075). This missense change has been observed in individual(s) with clinical features of peroxisome biogenesis disorder (PMID: 30078639). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs769772100, gnomAD 0.004%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 287 of the PEX16 protein (p.Arg287Cys). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 08, 2022 | Variant summary: PEX16 c.859C>T (p.Arg287Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250094 control chromosomes. c.859C>T has been reported in the literature in three siblings from the same family who were affected with Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum (Al-Shamsi_2016, Zaabi_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 16, 2021 | - - |
Peroxisome biogenesis disorder 8A (Zellweger) Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Peroxisome biogenesis disorder 8B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | Likely pathogenicity based on finding it once in our laboratory homozygous in an 8-year-old male with adrenoleukodystrophy - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at